Milestone Pharmaceuticals (MIST) Current Leases (2019 - 2026)
Milestone Pharmaceuticals (MIST) posted Current Leases of $659000.0 for Q1 2026, up 1.85% on a QoQ basis from $647000.0 in Q4 2025, and up 21.59% year-over-year from $542000.0 in Q1 2025.
Milestone Pharmaceuticals (MIST) Current Leases (2019 - 2026) Analysis & Trends
Milestone Pharmaceuticals' Current Leases history runs 8 years deep, the most recent figure standing at $659000.0 for Q1 2026.
- Quarterly Current Leases rose 21.59% year-over-year to $659000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $659000.0 (up 21.59% YoY) and the FY2025 annual result came in at $647000.0, up 13.31% from the prior year.
- Current Leases was $659000.0 for Q1 2026 at Milestone Pharmaceuticals, up from $647000.0 in the prior quarter.
- Across five years, Current Leases topped out at $659000.0 in Q1 2026 and bottomed at $169000.0 in Q2 2022.
- A 5-year average of $504411.8 and a median of $530000.0 in 2023 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2022 — Current Leases tumbled 34.75% — and 2023, when it soared 208.88%.
- Milestone Pharmaceuticals' Current Leases stood at $495000.0 in 2022, then grew by 10.3% to $546000.0 in 2023, then grew by 4.58% to $571000.0 in 2024, then grew by 13.31% to $647000.0 in 2025, then increased by 1.85% to $659000.0 in 2026.
- Business Quant data shows MIST's Current Leases at $659000.0 in Q1 2026, $647000.0 in Q4 2025, and $483000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Milestone Pharmaceuticals | 156.34 Mn | -27.87 Mn | - | 659,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 659,000.00 |
| Dec 31, 2025 | 647,000.00 |
| Sep 30, 2025 | 483,000.00 |
| Jun 30, 2025 | 515,000.00 |
| Mar 31, 2025 | 542,000.00 |
| Dec 31, 2024 | 571,000.00 |
| Sep 30, 2024 | 582,000.00 |
| Jun 30, 2024 | 567,000.00 |
| Mar 31, 2024 | 555,000.00 |
| Dec 31, 2023 | 546,000.00 |
| Sep 30, 2023 | 530,000.00 |
| Jun 30, 2023 | 522,000.00 |
| Mar 31, 2023 | 507,000.00 |
| Dec 31, 2022 | 495,000.00 |
| Sep 30, 2022 | 487,000.00 |
| Jun 30, 2022 | 169,000.00 |
| Mar 31, 2022 | 198,000.00 |
| Dec 31, 2021 | 224,000.00 |
| Sep 30, 2021 | 254,000.00 |
| Jun 30, 2021 | 259,000.00 |